跳至主要内容
临床试验/JPRN-jRCTs032200076
JPRN-jRCTs032200076已完成未知

Safety verification study of the new peripheral intravenous catheter for reducing catheter failure incidence: An exploratory study

Kurokawa Mineo0 个研究点目标入组 9 人开始时间: 2020年8月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
9

研究概览

简要总结

When a new catheter was indwelled in the upper arm vein for infusion, no adverse event occurred. In some cases, temporary occlusion alarm of the infusion pump was encountered. However, the frequency was not high considering the frequency of catheter failure in commonly used catheters, and treatment was not interrupted. Therefore, it was confirmed that the new catheter could be used safely by examining the cause of the malfunction that occurred during this investigation and taking countermeasures.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Who are scheduled to administrate stimulating drugs* (excluding anticancer drugs) using PIVC. (*Cytotoxic agents, Vesicant solutions, Irritant solutions, Hyperosmotic agents)
  • 2)Over 19 years, regardless of gender
  • 3)Who can expect continuous infusion therapy over 24 hours
  • 4)Who have obtained their own written consent

排除标准

  • 1)Who are unable to maintain the position to fully rotate the shoulder joint and rotate the elbow joint
  • 2)With skin disorders at the puncture site
  • 3)With peripheral neuropathy
  • 4)With a history of vasovagal reflex due to puncture
  • 5)With a history of thrombosis
  • 6)With end-stage renal disease (stage II or higher)
  • 7)With abnormal blood coagulation or bleeding tendency (PT-INR 1.5 or more, APTT 36.1 seconds or more, while taking any anticoagulant or antiplatelet drug)
  • 8)Who is planned of highly invasive tests (endoscopy, bronchoscopy)
  • 9)Whose physician judges that participation in this study is inappropriate

研究者

发起方
Kurokawa Mineo

相似试验